Autoimmune and clinical characteristics of Type I diabetes in children with different genetic risk loads defined by HLA-DQB1 alleles

Clinical Science

Volumn 94, Issue 3, 1998, Pages 263-269

  Komulainen, J ^a   Knip, M ^b   Sabbah, E ^c   Vahasalo P ^c   Lounamaa, R ^d   Akerblom H K ^e   Reijonen, H ^f   Ilonen, J ^f  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d KANTA HÄME CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

Autoantibodies; Clinical characteristics; Genetic susceptibility; Type I diabetes

Indexed keywords

AUTOANTIBODY; C PEPTIDE; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; HLA DQB1 ANTIGEN; PANCREAS ISLET CELL ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ALLELE; ARTICLE; AUTOIMMUNE DISEASE; CELL DESTRUCTION; CHILD; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOGENETICS; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET BETA CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

EID: 0031932996     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940263     Document Type: Article

References (31)

1. Wassmuth R, Lernmark Å. The genetics of susceptibility to diabetes. Clin Immunol Immunopathol 1989; 53: 358-99.
2. Karjalainen J, Salmela P, Ilonen J, Surcel H-M, Knip M. A comparison of childhood and adult Type I diabetes mellitus. N Engl J Med 1989; 320: 881-6.
3. Caillat-Zucman S, Garchon H-J, Timsit J, et al. Age-dependent HLA genetic heterogeneity of Type I insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242-50.
4. Ludvigsson J, Lindblom B. Human lymphocyte antigen DR types in relation to early clinical manifestations in diabetic children. Pediatr Res 1984; 18: 1239-41.
5. Eberhardt MS, Wagener DK, Orchard TJ, et al. HLA-heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study. Diabetes 1985; 34: 1247-52.
6. Drash A. Clinical care of the diabetic child. Chicago: Year Book Medical Publishers, Inc., 1986.
7. Ludvigsson J, Samuelsson U, Beauforts C, et al. HLA-DR3 is associated with a more slowly progressive form of Type I (insulin-dependent) diabetes. Diabetologia 1986; 29: 207-10.
8. Mustonen A, Ilonen J, Tiilikainen A, Kataja M, Åkerblom HK. An analysis of epidemiological data in HLA-typed diabetic children. Diabetologia 1985; 28: 397-400.
9. Knip M, Ilonen J, Mustonen A, Åkerblom HK. Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with Type I (insulin-dependent) diabetes. Diabetologia 1986; 29: 347-51.
10. Owerbach D, Lemmark Å, Platz P, et al. HLA-D region b-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature (London) 1983; 303: 815-17.
11. Cohen-Haguenauer O, Robbins E, Massart C et al. A systematic study of HLA class II-b DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Nad Acad Sci USA 1985; 82: 3335-9.
12. Reijonen H, Ilonen J, Knip M, Åkerblom HK. HLA-DQBI alleles and absence of Asp-57 susceptibility factors of IDDM in Finland. Diabetes 1991; 40: 1640-4.
13. Pugliese A, Gianani R, Moromisato R, et al. HLA-DQBI *0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes 1995; 44: 608-13.
14. Ilonen J, Reijonen H, Herva E, et al. Rapid HLA-DQBI genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 1996; 19: 795-800.
15. Nakanishi K, Kobayashi T, Murase T, et al. Association of HLA-A24 with complete beta-cell destruction in IDDM. Diabetes 1993; 41: 1086-93.
16. Schiffrin A, Ciampi A, Hendricks L, Rozen R, Weitzner G. Evidence for different clinical subtypes of Type I diabetes mellitus: a prospective study. Diabetes Res Clin Pract 1994; 23: 95-102.
17. Veijola R, Knip M, Reijonen H, Vähäsalo P, Puukka R, Ilonen J. Effect of genetic risk load defined by HLA-DQBI polymorphism on clinical characteristics of IDDM in children. Eur J Clin Invest 1995; 25: 106-12.
18. Vandewalle CL, Decraene T, Schuit FC, De Leeuw IH, Pipeleers DG, Gorus FK. Insulin autoantibodies and high titre islet cell antibodies are preferentially associated with the HLA DQAI *0301-DQBI *0302 haplotype at clinical onset of Type I (insulin-dependent) diabetes mellitus before age 10 years, but not at onset between age 10 and 40 years. Diabetologia 1993; 36: 1155-62.
19. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E, et al. Epidemiology of childhood diabetes mellitus in Finland - background of a nationwide study of Type I (insulin-dependent) diabetes mellitus. Diabetologia 1992; 35: 70-6.
20. Sjöroos M, litiä A, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for Type I diabetes-related HLA alleles. BioTechniques 1995; 18: 870-7.
21. Bottazzo GF, Florin-Christiansen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; ii: 1279-82.
22. Lernmark Å, Molenaar JL, van Beers WM, et al. The fourth international serum exchange workshop to standardize cytoplasrnic islet cell antibodies. Diabetologia 1992; 35: 70-7.
23. Palmer JP, Asplin CM, Clemons P, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337-9.
24. Petersen JS, Hejnaes KR, Moody HA, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994; 43: 459-67.
25. Schmidli RS, Colman PG, Bonifacio E, et al. disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. The Second International GADab Workshop. Diabetes 1995; 44: 636-40.
26. Heding LG. Radioimmunological determination of human C-peptide in serum. Diabetologia 1975; 11: 541-8.
27. Arslanian SA, Becker DJ, Rabin B, et al. Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy. Diabetes 1985; 34: 926-30.
28. Kolb H, Dannehl K, Grueneklee D, et al. Prospective analysis of islet cell antibodies in children with Type I (insulin-dependent) diabetes. Diabetologia 1988; 31: 189-94.
29. Hagopian WA, Sanjeevi CB, Kockrin I, et al. Glutamate decarboxylase, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children, J Clin Invest 1995; 95: 1505-11.
30. Karjalainen J, Knip M, Mustonen A, Åkerblom HK. Insulin autoantibodies at the dinical manifestation of Type I (insulin-dependent) diabetes: a poor predictor of clinical course and antibody response to exogenous insulin. Diabetologia 1988; 31: 129-33.
31. Rjasanowski I, Michaelis D, Keilacker H, Besch W, Richter KV, Heinke P. 5-year follow-up study of C-peptide secretion in newly diagnosed Type I diabetes: relations to HLA-phenotype, insulin requirement and metabolic control. Exp Clin Endocrinol 1987; 89: 216-24.